The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancer

Urological Research

Volumn 30, Issue 1, 2002, Pages 59-65

  Crook, T J ^a   Dyer, J P ^a   McCormick, R I ^a   Birch, B R ^a   Cooper, A J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; Explant; GFP; MeGLA; MGH U1 cell line

Indexed keywords

ANTINEOPLASTIC AGENT; GREEN FLUORESCENT PROTEIN; MEGLUMINE GAMMA LINOLENIC ACID; MITOMYCIN C; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLADDER; BLADDER CANCER; CLINICAL TRIAL; CONFOCAL MICROSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; EXPLANT; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; MONOLAYER CULTURE; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; UROGENITAL TRACT TUMOR;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; GAMMA-LINOLENIC ACID; HUMANS; MEGLUMINE; NEOPLASMS, EXPERIMENTAL; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; URINARY BLADDER NEOPLASMS;

EID: 0036936434     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-001-0224-3     Document Type: Article

References (23)

1. Begin ME (1989) Tumour cytotoxicity of essential fatty acids. Nutrition 15: 258
2. Chalfie M (1995) Green fluorescent protein. Photochem Photobiol 62: 651
3. Crook TJ, Hall IS, Solomon LZ, Bass PS, Cooper AJ, Birch BRP (2000) Intravesical meglumine gamma linolenic acid. Phase I Tolerability studies in patients undergoing cystectomy. UroOncology 1: 39
4. Crook TJ, Hall IS, Solomon LZ, Birch BR, Cooper AJ (2000) A model of superficial bladder cancer using fluorescent tumour cells in an organ-culture system. BJU Int 86: 886
5. Davies CL, Crook TJ, French R, Cooper AJ Characterisation of GFP transfected MGHU-1 cells for use in an in vitro model of bladder cancer. UroOncology (in press)
6. Duffy PM, Hayes MC, Cooper AJ, Smart C (1996) Determination and reversal of resistance to epirubicin intravesical chemotherapy. A flow cytometric study. Br J Urol 77: 819
7. Evans DR, Irwin RJ, Havre PA, Bouchard JG, Kato T, Prout GR (1977) The activity of the pyrimidine biosynthetic pathway in MGH-U1 transitional carcinoma cells grown in tissue culture. J Urol 117: 712
8. Fearon KCH, Falconer JS, Ross JA, Carter DC, Hunter JO, Reynolds PD (1996) An open label phase I/II dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate. Anticancer Res 16: 867
9. Gratzner HG, Leif RC, Ingram DJ, Castro A (1975) The use of antibody specific for bromodeoxyuridine for the immunofluorescent determination of DNA replication in single cells and chromosomes. Exp Cell Res 95: 88
10. Gubin AN, Reddy B, Njoroge JM, Miller JL (1997) Long-term, stable expression of green fluorescent protein in mammalian cells. Biochem Biophys Res Commun 236: 347
11. Hodges GM, Hicks RM, Spacey GD (1976) Scanning electron microscopy of cell-surface changes in methylnitrosurea (MNU)-treated rat bladders in vivo and in vitro. Differentiation 6: 143
12. Nicholson LJ Jani H (1988) Effects of sodium cyclamate and sodium saccharin on focus induction in explant cultures of rat bladder. Int J Cancer 42: 295
13. Oshinsky GS, Chen Y, Jarrett T, Anderson AE, Weiss GH (1995) A model of bladder tumour xenografts in the nude rat. J Urol 154: 1925
14. Pode D, Alon Y, Horowitz AT, Vlodavsky I, Biran S (1986) The mechanism of human bladder tumor implantation in an in vitro model. J Urol 136: 482
15. Pritchett TR, Wang JK, Jones PA (1989) Mesenchymal-epithelial interactions between normal and transformed human bladder cells. Cancer Res 49: 2750
16. Rebel JM, Thijssen CD, Vermey M, Zwarthoff EC, van der Kwast TH (1995) Modulation of intra-epithelial expansion of human T24 bladder-carcinoma cells in murine urothelium by growth factors and extra-cellular-matrix components. Int J Cancer 60: 707
17. Reedy EA, Heatfield BM (1987) Histomorphometry and cell kinetics of normal human bladder mucosa in vitro. Urol Res 15: 321
18. Solomon LZ, Jennings AM, Foley SJ, Birch BRP, Cooper AJ (1998) Bladder cancer recurrence by implantation of exfoliated cells: is gamma-linolenic acid an effective tumoricidal agent? Br J Urol 82: 122
19. Solomon LZ, Jennings AM, Hayes MC, Bass PS, Birch BRP, Cooper AJ (1998) Is gamma-linolenic acid an effective intravesical agent for superficial bladder cancer? In vitro cytotoxicity and in vivo tolerance studies. Urol Res 26: 11
20. Solomon LZ, Birch BRP, Cooper AJ (1998) Water as a tumoricidal agent in bladder cancer. Eur Urol 34: 500
21. Sterle M, Kreft ME, Batista U (1997) The effect of epidermal growth factor and transforming growth factor beta 1 on proliferation and differentiation of urothelial cells in urinary bladder explant culture. Biol Cell 89: 263
22. Tucker GC, Delouvee A, Jouanneau J, Gavrilovic J, Moens G, Valles AM, Thiery JP (1991) Amplification of invasiveness in organotypic cultures after NBT-II rat bladder carcinoma stimulation with in vitro scattering factors. Invasion Metastasis 11: 297
23. Wientjes MG, Dalton JT, Badalament RA, Drago JR, Au JL (1991) Bladderwall penetration of intravesical mitomycin C in dogs. Cancer Res 51: 4347